This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Pernix Therapeutics Holdings Inc (PTX)

NASDAQ: Health Care

Company Cash Flow
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Cash Flow From Operating Activities
Net Income (Loss) -148.31M -35.29M -25.64M -1.41M
Operating Gains/Losses n.a. n.a. n.a. n.a.
Extraordinary Gains / Losses n.a. n.a. n.a. n.a.
(Increase) Decrease In Receivables n.a. n.a. n.a. n.a.
(Increase) Decrease in Inventories n.a. n.a. n.a. n.a.
(Increase) Decrease In Other Current Assets -21.23M -18.48M 12.16M -3.89M
(Decrease) Increase In Payables n.a. n.a. n.a. n.a.
(Decrease) Increase In Other Current Liabilities 19.05M 40.49M -6.37M -770.38K
(Increase) Decrease In Other Working Capital n.a. n.a. n.a. n.a.
Other Non-Cash Items 129.00M 33.92M 35.83M 5.98M
Net Cash From Continuing Operations n.a. n.a. n.a. n.a.
Net Cash From Discontinued Operations n.a. n.a. n.a. n.a.
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -14.75M 8.90M -6.53M -1.93M
Sale of Property, Plant & Equipment n.a. n.a. n.a. n.a.
Cash Used for Investing Activities
Sale of Short-Term Investments 4.85M 4.85M 4.61M 0.00
Purchases of Property, Plant & Equipment -1.21M -1.13M -496.04K -318.74K
Acquisitions -87.99M -253.81M -309.59K -56.33M
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities 0.00 175.00K 19.59M -8.25M
Cash Provided by Financing Activities
Net Cash From Investing Activities -84.35M -249.92M 23.39M -64.90M
Issuance of Debt 130.00M 285.00M 0.00 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 395.00K 2.30M 261.44K 24.59M
Repayment of Long-Term Debt -44.00K -12.06M -24.34M -3.54M
Repurchase of Capital Stock 0.00 0.00 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net -9.97M -15.01M -151.50K 34.25M
Net Cash From Financing Activities 120.38M 260.23M -24.23M 55.29M
Effect of Exchange Rate Changes 0.00 0.00 0.00 0.00
Net Change in Cash & Cash Equivalents 21.28M 19.21M -7.38M -11.53M
PTX News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

PTX Pernix Therapeutics Holdings Inc

Chart of PTX

Analysts Ratings for PTX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 3 3
Moderate Buy 0 0 0 0
Hold 2 2 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET PTX ANALYST REPORT

PTX Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs